FCC Examines Device Role In Next-Generation 911 Emergency Response
This article was originally published in The Gray Sheet
Medical telemetry data should be considered a primary media application in next-generation 911 emergency response systems, a mobile health industry group is advising the Federal Communications Commission.
You may also be interested in...
FCC seeks input on next-gen 911 service
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.